Eyes that Do Not Meet the Eligibility Criteria of Clinical Trials on Age-Related Macular Degeneration: Proportion of the Real-World Patient Population and Reasons for Exclusion
Background. To evaluate the proportion of eyes that do not meet the eligibility criteria of clinical trials on neovascular age-related macular degeneration (AMD) and the reasons for exclusion. Methods. This retrospective, observational study included 512 eyes of 463 patients diagnosed with treatment...
Main Authors: | Jae Hui Kim, Jong Woo Kim, Chul Gu Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2021/6635467 |
Similar Items
-
Investigation of the Trend of Selecting Anti-Vascular Endothelial Growth Factor Agents for the Initial Treatment of Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
by: Jae-Hui Kim, et al.
Published: (2021-08-01) -
Age-related macular degeneration and the aging eye
by: Rita Ehrlich, et al.
Published: (2008-09-01) -
Depression and anxiety in age-related macular degeneration
by: Kim ES, et al.
Published: (2016-10-01) -
Nutrients for Prevention of Macular Degeneration and Eye-Related Diseases
by: Hock Eng Khoo, et al.
Published: (2019-04-01) -
Retinal vascular flow and choroidal thickness in eyes with early age-related macular degeneration with reticular pseudodrusen
by: So Min Ahn, et al.
Published: (2018-07-01)